Global Grand Challenges
  • Grant Opportunities
  • Challenges
  • Awards
  • Champions
  • Partnerships
  • News
  • About

siRNA Larvicides for Control of Malaria Vector Mosquitoes

Molly Duman Scheel of Indiana University in the U.S. will perform a high-throughput screen to identify small interfering (si)RNAs that cause death when ingested by mosquito larvae as a method for reducing malaria transmission. Malaria vector mosquitoes are developing resistance to current larval insecticides, which are used to complement other control strategies such as insecticide-treated nets. They have shown that small RNAs combined with chitosan nanoparticles are ingested by mosquito larvae and can silence their gene targets. They will perform a screen of siRNAs targeting 1000 candidate larval essential genes in the malaria vector mosquito Anopheles gambiae at different developmental stages. Identified lethal siRNAs will be tested in multiple Anopheline species to target malaria spread by other species.

More information about New Approaches for Addressing Outdoor/Residual Malaria Transmission (Round 14)

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

The Bill & Melinda Gates Foundation is part of the Grand Challenges partnership network. Visit www.grandchallenges.org to view the map of awarded grants across this network and grant opportunities from partners.